 dual modul leucovorin hydroxyurea phase trial oral hydroxyurea HU regimen leucovorin lcv continu infus day previou report lcv infus optim dosag agent oral HU regimen total dosag g/d g/d g/d g/d twenty-two patient total cours treatment stomat dose-limit side effect cours HU g/d cours HU g/d escal g/d g/d possibl patient median time day rang day respons popul phase II trial HU lcv dual modul infusion initi HU dosag g/d regimen dose escal variabl oral absorpt account small group patient dose HU